No abstract available
Keywords:
Gefitinib; Molecularly targeted therapy; NSCLC; Precision oncology; TKI.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenocarcinoma of Lung / drug therapy*
-
Adenocarcinoma of Lung / genetics
-
Adenocarcinoma of Lung / pathology
-
Afatinib / therapeutic use*
-
ErbB Receptors / antagonists & inhibitors
-
ErbB Receptors / genetics
-
Exons*
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / genetics
-
Lung Neoplasms / pathology
-
Male
-
Middle Aged
-
Mutation*
-
Prognosis
-
Protein Kinase Inhibitors / therapeutic use*
Substances
-
Protein Kinase Inhibitors
-
Afatinib
-
EGFR protein, human
-
ErbB Receptors